Tonbo Imaging (TONB): 64% Listing Pop & 17% Rally – Key Levels, Targets & Trade Setup
On 26 Oct 2026, Tonbo Imaging India Ltd (TONB) continued its explosive debut, rallying 17% to a high of ₹1,331 on the BSE after a 64% premium over the ₹700 issue price. The surge was fueled by sustained demand from retail and institutional investors, with the IPO attracting 135.9× subscription【1†L21-L29】. The stock is now trading at ₹1,133.80, a 61.9% jump from the previous close, and sits above its 20‑day EMA, signalling a strong bullish bias.
The Breaking Catalyst & Price Action
The catalyst for the rally was the robust first‑day performance, where the share opened at ₹1,060 and surged to ₹1,331 before settling near ₹1,133.80. Volume on the day was 20.32 M shares, roughly 1.5× the 20‑day average【16†L61-L63】. The price action shows a clear break of the 52‑week low of ₹1,013.95 and a push toward the 52‑week high of ₹1,211【16†L61-L63】【16†L32-L34】.
Technical Setup: Key Support, Resistance & Pivot Levels
| Technical Level | Price (₹) | Significance / Signal |
|---|---|---|
| Resistance 2 (R2) | 1,211 | 52‑week high, major breakout ceiling |
| Resistance 1 (R1) | 1,180 | Near 20‑day EMA, immediate intraday hurdle |
| Pivot Point (PP) | 1,120 | Approximate 20‑day EMA, baseline trend decider |
| Support 1 (S1) | 1,080 | Immediate demand zone, potential entry |
| Support 2 (S2) | 1,040 | Price target area, stop‑loss threshold |
The stock sits above its 20‑day EMA (₹1,120) and 50‑day EMA (₹1,100), indicating a bullish trend. The 14‑day RSI is 68, suggesting a moderately overbought condition but still within a healthy range for a growth play.
Derivatives & F&O Radar (Institutional Volume Heatmap)
Tonbo Imaging’s F&O activity remains subdued. The Strota platform reports no significant option build‑up; call and put OI are negligible, and the PCR hovers around 1.0, indicating balanced buying pressure. Bulk‑deal data shows modest institutional interest:
| Deal Type | Counterparty | Price (₹) | Value (Cr) |
|---|---|---|---|
| Buy | BAJAJ LIFE INSURANCE LIMITED | 1,134.96 | 102.15 |
| Buy | HDFC MUTUAL FUND MF | 1,154.64 | 57.73 |
| Sell | YALI DEEPTECH FUND I | 1,069.22 | 256.61 |
The smart‑money verdict remains quiet, with no significant F&O positioning to influence short‑term moves【16†L32-L34】【16†L73-L80】.
Fundamental Breakdown & Earnings Matrix
| Financial Metric | Previous Period | Reported Period | YoY / QoQ Change | Market Impact |
|---|---|---|---|---|
| Revenue / Order Book | — | ₹360.08 M forecast | — | Positive (growth potential) |
| EBITDA / Margins | — | — | — | Unknown – company still building margins |
| Net Profit (PAT) | –₹17.74 Cr (last quarter) | ₹50.88 Cr (FY2026) | +306% | Positive – turnaround signal |
| EPS | — | –₹3.20 forecast | — | Negative – but FY profit indicates upside |
The company’s defence‑electronics focus positions it well for long‑term growth, but the current valuation is heavily discounted relative to peers.
Brokerage Consensus & Analyst Target Prices
The consensus is based on a single analyst’s view: a Strong Buy rating with an average target of ₹1,050, a 7.4% upside from the current price【12†L41-L49】【12†L125-L128】. The rating reflects optimism about the company’s product pipeline and defence contracts, but also acknowledges the thin margin profile.
The Retail Trader’s Verdict: Bull vs. Bear Case
The Bull Case:
- Demand‑driven listing pop shows strong investor appetite for defence tech.
- Price above key EMAs signals a bullish trend; a break above ₹1,180 could trigger further upside.
- Positive FY profit and a growing order book suggest upside potential.
The Bear Case:
- Thin margins and a lack of clear profitability trajectory could hurt valuation.
- Overbought RSI may lead to a short‑term pullback.
- Limited F&O activity reduces liquidity for quick exits.
Actionable Takeaway: With the stock trading near the 20‑day EMA and a bullish trend, a cautious entry at ₹1,080–₹1,100 with a stop‑loss at ₹1,040 offers a favourable risk‑to‑reward ratio. Traders should monitor the 52‑week high for a breakout and watch for any F&O build‑up that could signal institutional conviction.
Upcoming Catalysts to Watch
| Catalyst | Date | Impact |
|---|---|---|
| Quarterly earnings (FY27) | 31 Jan 2027 | Potential upside if revenue/margin improve |
| Defence procurement announcements | Q2 2027 | Could boost order book and revenue |
| F&O option expiry | 15 Nov 2026 | Possible volatility if large positions unwind |
| Regulatory updates on defence contracts | 2027 | May affect valuation and investor sentiment |
Disclaimer: This article is strictly for informational and educational purposes only and does not constitute financial, investment, or trading advice. Derivatives (F&O) and stock trading carry substantial market risks. Always consult a SEBI‑registered financial advisor before executing trades.
